Source - LSE Regulatory
RNS Number : 7496U
Spectra Systems Corporation
08 April 2021
 

Spectra Systems Corporation

 

Allowance of Banknote Disinfection Patent by the United States Patent and Trademark Office

 

Spectra Systems Corporation, a leading provider of advanced technology solutions for banknote and product authentication and gaming security, is pleased to announce that it has received a notice of allowance from the United States Patent and Trademark Office for its technology for disinfecting banknotes from SARS-2 and other biohazards.  The patent is expected to be issued within 6 weeks.  Additionally, patent applications have been filed in other regions worldwide.

 

The technology can disinfect five million notes in less than 2 hours and uses nitrogen obtained from the ambient air to create an oxygen-free atmosphere, along with heat, to deactivate SARS-2.

 

 

Commenting on the results, Nabil Lawandy, Chief Executive Officer, said:

 

"The Covid-19 pandemic has raised questions about the health safety of banknotes.  Given that several new SARS-2 variants have been shown to be more virulent, it is likely that Covid-19 will become endemic.  Central banks and Casinos that exchange cash with the public may conclude that a proactive approach rather than denial is the logical approach to maintaining the use of cash worldwide. Our newest product is designed specifically to address this situation effectively, and its patent was we understand allowed in record time"

 

Enquiries:

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer                                                 Tel: +1 (0) 401 274 4700

 

 

WH Ireland Limited

Chris Fielding (Managing Director, Corporate Finance)                              Tel: +44 (0) 20 7220 1650

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIGDSDXGDGBR
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.